RhinAer
RhinAer is a minimally invasive, in-office radiofrequency treatment for chronic rhinitis delivered via the RhinAer Stylus.
Last updated September 29, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
RhinAer is a medical device brand centered on a single, clearly defined offering: the RhinAer Stylus, an in-office treatment for chronic rhinitis. Chronic rhinitis is described by the brand as a common and frequently undiagnosed condition whose hallmark symptoms are a constant runny nose, persistent post-nasal drip, congestion or a frequent "stuffed up" feeling, and excessive sneezing. The brand positions these symptoms as nerve-driven rather than purely allergy-driven, noting that chronic rhinitis is caused by overactive nerve signals and inflamed soft tissue in the nose, and that symptoms often persist beyond allergy season. The RhinAer procedure is performed by an ear, nose and throat (ENT) physician. According to the brand's patient information, the physician uses the RhinAer Stylus to apply low-temperature radiofrequency technology to calm the abnormal or overactive nerves inside the nose that are causing symptoms. The brand emphasizes that the treatment is non-invasive, involves minimal discomfort, and that patients can typically return to normal daily activities immediately afterward. RhinAer is marketed as an alternative for people who find that daily medications, sprays and coping behaviors provide only short-term relief; the site cites a survey of 104 patients in which 40% said such medications do not do enough. RhinAer's communication is built around patient education and self-assessment. The website offers a Total Nasal Symptom Score (TNSS) questionnaire that lets visitors gauge the severity of their chronic rhinitis, and it explains the difference between allergic and non-allergic rhinitis. The brand states that a TNSS of 5 or higher may indicate a good candidate for treatment, while stressing that candidacy ultimately depends on individual needs and nasal anatomy and should be determined in consultation with a local ENT physician. A physician-finder tool directs patients to local providers. On efficacy, the brand reports that in a clinical study 88% of patients treated with RhinAer had improved chronic rhinitis symptoms after a two-year follow-up, which it presents as evidence that results are long-lasting, while acknowledging that the full duration of benefit is still being measured. The brand's clinical references include a published paper on long-term outcomes following temperature-controlled radiofrequency neurolysis for chronic rhinitis. RhinAer is a product brand of Aerin Medical, a medical device company. The brand operates primarily in the United States and is distributed through ENT physician practices rather than direct-to-consumer retail channels. Its identity is that of a focused, procedure-based therapeutic brand rather than a broad consumer healthcare line.
History
RhinAer is a product brand of Aerin Medical, a medical device company, and is built around a single therapeutic technology: temperature-controlled radiofrequency neurolysis delivered through the RhinAer Stylus for the treatment of chronic rhinitis. The brand's public identity is defined less by a long corporate chronology than by the clinical development and commercialization of that procedure. The clinical foundation cited by the brand is a study of long-term outcomes following temperature-controlled radiofrequency neurolysis for chronic rhinitis, referenced on the RhinAer patient FAQ page. According to the brand, in a clinical study 88% of patients treated with RhinAer had improved chronic rhinitis symptoms after a two-year follow-up, which the brand presents as evidence that results are long-lasting while noting that the full duration of treatment benefits is still being measured. Commercially, RhinAer has been positioned as an in-office alternative for chronic rhinitis sufferers who are dissatisfied with conventional management. The brand's website cites a survey of 104 patients in which 40% said daily medications and sprays do not do enough, framing the procedure as a more permanent solution after years of symptom management. The treatment is performed by ENT physicians, and the brand maintains a physician-finder tool to connect patients with local providers. The brand's patient-facing materials emphasize education: explaining what chronic rhinitis is, distinguishing allergic from non-allergic rhinitis, listing hallmark symptoms such as constant runny nose, post-nasal drip, congestion and excessive sneezing, and offering a Total Nasal Symptom Score (TNSS) questionnaire for self-assessment. The brand states that a TNSS of 5 or higher may indicate a good candidate for treatment, while deferring the final determination to a consultation with a local ENT physician. RhinAer operates primarily in the United States and is distributed through ENT practices rather than retail channels. As a brand of Aerin Medical, it sits within the medical device sector rather than the consumer packaged goods or pharmaceutical sectors, and its marketing is directed both at patients seeking relief and at the physicians who perform the procedure.
Clinical study of temperature-controlled radiofrequency neurolysis for chronic rhinitis is referenced by the brand, reporting 88% of treated patients with improved symptoms at two-year follow-up.
RhinAer is commercialized as an in-office ENT procedure delivered via the RhinAer Stylus.
The brand launches patient-facing educational resources including a Total Nasal Symptom Score (TNSS) questionnaire and a physician-finder tool.
Products and positioning
A minimally invasive, in-office ENT procedure offering lasting relief from chronic rhinitis symptoms for patients poorly served by medications and sprays.
RhinAer Stylus
A handheld stylus used by ENT physicians to apply low-temperature radiofrequency technology to calm abnormal or overactive nerves inside the nose causing chronic rhinitis symptoms.
RhinAer procedure
A convenient, in-office, non-invasive treatment designed to address the underlying causes of chronic rhinitis and reduce runny nose, post-nasal drip and congestion.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/rhinaer · Editorial policy · How profiles are compiled